SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01) | 1 mg

Sequence:	LLLDRLNQL
Gene:	N
Delivery:	1-3 days
C-Terminus:	OH
N-Terminus:	H
Amount:	1 mg
Counterion:	TFA
Protein:	Nucleoprotein
Species:	SARS-CoV-2
Allele:	HLA-A*02:01
Application:	Flow Cytometry
Indication:	Infectious disease
Purity:	95% HPLC-MS

SARS-CoV-2 (M-Protein) Peptide Pool

Pool of 53 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt: P0DTC5) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT) One unit allows the stimulation of 2,5 x 108 cells.

€277.50*

SARS-CoV-2 (N-Protein) Peptide Pool

Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt: P0DTC9) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.

€316.90*

SARS-CoV-2 (NS6) Peptide Pool

Pool of 13 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-Structural protein 6 (UniProt: P0DTC6) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT) One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 (NS7a) Peptide Pool

Pool of 28 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural protein 7A (UniProt: P0DTC7) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 (NS7b) Peptide Pool

Pool of 8 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural Protein 7b (UniProt: P0DTD8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 (NS8) Peptide Pool

Pool of 28 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Non-structural protein 8 (UniProt: P0DTC8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 (ORF10) Peptide Pool

Pool of 7 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire ORF10 Protein (UniProt: A0A663DJA2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 (ORF3a) Peptide Pool

Pool of 66 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein ORF3a (UniProt: P0DTC3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 108 cells.

€316.90*

SARS-CoV-2 (ORF9b) Peptide Pool

Pool of 22 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Protein 9b (UniProt: P0DTD2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT) One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 (ORF9c) Peptide Pool

Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Uncharacterized ORF9c protein (UniProt: P0DTD3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT) One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

Tip

SARS-CoV-2 (Spike Glycoprotein) Peptide Pool

Pool of 316 overlapping peptides (delivered in two subpools of 158 & 158 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT) One unit allows the stimulation of 2,5 x 108 cells.

€634.00*

SARS-CoV-2 (VEMP) Peptide Pool

Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope small membrane protein (UniProt: P0DTC4) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT) One unit allows the stimulation of 2,5 x 108 cells.

€237.50*

SARS-CoV-2 Membrane GP A2 61-70 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The membrane glycoprotein is present on the coronavirus envelope and it has an important role in virion assembly. SARS-CoV-2 Membrane GP A2 61-70 (HLA-A*02:01) is a linear peptidic epitope studied as part of membrane glycoprotein from severe acute respiratory syndrome-related coronavirus.

From €106.60*

Details

SARS-CoV-2 Membrane GP A2 89-97 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The membrane glycoprotein is present on the coronavirus envelope and it has an important role in virion assembly. SARS-CoV-2 Membrane GP A2 89-97 (HLA-A*02:01) is a linear peptidic epitope studied as part of membrane glycoprotein from severe acute respiratory syndrome-related coronavirus.

From €106.60*

Details

SARS-CoV-2 Membrane GP_1 A2 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The membrane glycoprotein is present on the coronavirus envelope and it has an important role in virion assembly. SARS-CoV-2 Membrane GP_1 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of membrane glycoprotein from severe acute respiratory syndrome-related coronavirus.

From €106.60*

Details

SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The membrane glycoprotein is present on the coronavirus envelope and it has an important role in virion assembly. SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of membrane glycoprotein from severe acute respiratory syndrome-related coronavirus. Based on recent studies, this sequence is one of the most promised MHC class I related peptides in envelope protein based vaccine of COVID-19.

From €106.60*

Details

SARS-CoV-2 Nucleocapsid_1 B7 (HLA-B*07:02)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV-2 Nucleocapsid_1 B7 (HLA-B*07:02) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in MHC ligand assays.

From €106.60*

Details

SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in MHC ligand assays.

From €106.60*

Details

SARS-CoV-2 Nucleocapsid_3 B7 (HLA-B*07:02)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV-2 Nucleocapsid_3 B7 (HLA-B*07:02) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in MHC ligand assays. Delivery Format: The product is supplied freeze dried as trifluoracetate salt

From €106.60*

Details

SARS-CoV-2 ORF3a prot_1 A2 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. SARS-CoV ORF3a prot_1 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of the ORF3a protein from severe acute respiratory syndrome-related coronavirus.

From €106.60*

Details

SARS-CoV-2 ORF3a prot_2 A2 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. SARS-CoV ORF3a prot_2 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of the ORF3a protein from severe acute respiratory syndrome-related coronavirus.

From €106.60*

Details

SARS-CoV-2 ORF6 prot_1 A2 (HLA-A*02:01)

Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. SARS-CoV ORF6 prot_1 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of the ORF6 protein from severe acute respiratory syndrome-related coronavirus.

From €106.60*

Details

SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01)

RLQSLQTYV is an antigen-specific SARS-CoV-2 peptide

From €106.60*

Details

Request a Quotation

Your Contact Information

Quotation Sent!

SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01) LLLDRLNQL

€106.60*

Description

TechData

Documents